AstraZeneca and Amgen's Phase 3 trial data shows Tezspire significantly reduces nasal polyps and congestion in patients with chronic rhinosinusitis with nasal polyps.
The safety profile and tolerability of TEZSPIRE in the trial were consistent with the known profile of the medicine ... called nasal polyps, and is most commonly treated with INCS and surgery ...